Maternal toxicity and pregnancy complications in human immunodeficiency virus–infected women receiving antiretroviral therapy: PACTG 316
D. Heather Watts(National Institutes of Health), Coleen K. Cunningham(Duke Medical Center), Mary Culnane(National Institute of Allergy and Infectious Diseases), Richard D. Gelber(Harvard University), Rajalakshmi Balasubramanian(SUNY Upstate Medical University), Marie‐Louise Newell(University of Cape Town), Alejandro Dorenbaum(University of California, San Francisco), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Isaac Delke(SUNY Upstate Medical University), Robert Maupin, Jean‐François Delfraissy, S. Fiore(SUNY Upstate Medical University)
Cited by 99
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k